Uncategorized

Jubilant draws FDA rebuke for delayed mold investigation and quality unit lapses

Published

on

Jubilant HollisterStier received a warning letter over problems that the FDA said necessitate an immediate and comprehensive assessment of the contract manufacturing organization’s global operations.

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version